Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 65.1	$ 62.0
Accounts receivable, net	36.5	31.6
Inventories, net	26.0	17.3
Income tax receivable	7.5	0.9
Prepaid expenses and other current assets	12.4	13.1
Total current assets	147.5	124.9
Property, plant and equipment, net	139.1	142.1
Operating lease right-of-use assets, net	22.2	23.7
Goodwill	446.8	450.1
Intangible assets, net	328.7	345.4
Deferred tax assets	0.1	0.1
Other assets	35.6	36.4
Total assets	1,120.0	1,122.7
Current liabilities
Accounts payable	26.2	17.6
Accrued liabilities and other	23.5	22.1
Current portion of long-term debt	2.6	2.5
Operating lease liabilities, current	3.9	3.8
Deferred revenue	2.4	2.0
Total current liabilities	58.6	48.0
Long-term debt	393.5	397.8
Deferred tax liabilities	72.4	71.6
Derivative instruments	4.3	6.3
Operating lease liabilities, non-current	22.5	24.7
Other liabilities	2.5	2.3
Total liabilities	553.8	550.7
Commitments and contingencies – Note 13
Shareholders’ equity
Additional paid-in capital	696.1	693.7
Accumulated deficit	(126.4)	(123.8)
Accumulated other comprehensive income (loss)	(3.5)	2.1
Total shareholders’ equity	566.2	572.0
Total liabilities and shareholders’ equity	1,120.0	1,122.7
Class A common stock, $0.0001 par, 200,000,000 shares authorized at June 30, 2024 and December 31, 2023 Shares issued and outstanding: 80,289,912 and 79,684,170 at June 30, 2024 and December 31, 2023, respectively
Shareholders’ equity
Common stock	0.0	0.0
Convertible Class C common stock, $0.0001 par, 200,000,000 shares authorized at June 30, 2024 and December 31, 2023 Shares issued and outstanding: 2,921,099 at June 30, 2024 and December 31, 2023
Shareholders’ equity
Common stock	$ 0.0	$ 0.0